Munafa Stock Market Course + Intraday & FNO calls 
Citius Pharmaceuticals (CTXR) Technical (Analysis) Reports Citius Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Citius Pharmaceuticals (CTXR)
Technical Analysis Report for USA stock CTXR Citius Pharmaceuticals. Dated: 05 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock CTXR Citius Pharmaceuticals then click here. or read Experts views on Citius Pharmaceuticals or Forecast & share price targets of Citius Pharmaceuticals
Citius Pharmaceuticals Opened at 1.24 and Closed at: 1.18, which is -7.63% of previous session's close. It moved within a range of 1.18 and 1.26
The session was a Bearish session with an average volume of 262900, which is -63.96% of previous session's volumes.
A Golden cross was found 4 days back on short term averages
Support for tomorrow is 1.14 and resistance for tomorrow is 1.22
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 1.15, 1.13 resistance for tomorrow's hourly charts is 1.23, 1.29
10 Day SMA for Citius Pharmaceuticals (CTXR) is 1.26 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Citius Pharmaceuticals (CTXR) is 1.17 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Citius Pharmaceuticals (CTXR) is 1.33 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 1.32 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Citius Pharmaceuticals is 1.27 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Citius Pharmaceuticals is at 1.17 and 200 DMA is at 1.27, while 50 DMA and 100 DMA are at 1.33 and 1.32 respectively
Citius Pharmaceuticals (CTXR) moving average of 20 SMA is at 1.17 and 20 EMA is at 1.23
| Date | Closing Price | 20 SMA | 20 EMA |
| 05 Fri Dec | 1.18 | 1.17 | 1.23 |
| 04 Thu Dec | 1.27 | 1.18 | 1.23 |
| 03 Wed Dec | 1.15 | 1.18 | 1.23 |
| 02 Tue Dec | 1.26 | 1.19 | 1.24 |
| 01 Mon Dec | 1.35 | 1.21 | 1.24 |
| 28 Fri Nov | 1.44 | 1.22 | 1.23 |
Citius Pharmaceuticals (CTXR) moving average of 50 SMA is at 1.33 and 50 EMA is at 1.28
| Date | Closing Price | 50 SMA | 50 EMA |
| 05 Fri Dec | 1.18 | 1.33 | 1.28 |
| 04 Thu Dec | 1.27 | 1.33 | 1.28 |
| 03 Wed Dec | 1.15 | 1.33 | 1.28 |
| 02 Tue Dec | 1.26 | 1.33 | 1.29 |
| 01 Mon Dec | 1.35 | 1.33 | 1.29 |
| 28 Fri Nov | 1.44 | 1.33 | 1.29 |
Citius Pharmaceuticals (CTXR) moving average of 100 SMA is at 1.32 and 100 EMA is at 1.35
| Date | Closing Price | 100 SMA | 100 EMA |
| 05 Fri Dec | 1.18 | 1.32 | 1.35 |
| 04 Thu Dec | 1.27 | 1.33 | 1.35 |
| 03 Wed Dec | 1.15 | 1.33 | 1.35 |
| 02 Tue Dec | 1.26 | 1.33 | 1.35 |
| 01 Mon Dec | 1.35 | 1.34 | 1.35 |
| 28 Fri Nov | 1.44 | 1.34 | 1.35 |
Citius Pharmaceuticals (CTXR) moving average of 200 SMA is at 1.27 and 200 EMA is at 1.27
| Date | Closing Price | 200 SMA | 200 EMA |
| 05 Fri Dec | 1.18 | 1.27 | 1.27 |
| 04 Thu Dec | 1.27 | 1.27 | 1.27 |
| 03 Wed Dec | 1.15 | 1.28 | 1.27 |
| 02 Tue Dec | 1.26 | 1.29 | 1.27 |
| 01 Mon Dec | 1.35 | 1.29 | 1.27 |
| 28 Fri Nov | 1.44 | 1.3 | 1.27 |
Pfizer Inc has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Pfizer Inc, about 12.06% more returns!
Nu Skin has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Nu Skin, about 15.03% more returns!
Haemonetics Corporation has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Haemonetics Corporation, about 28.39% more returns!
Chemed Corp has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Chemed Corp, about 2.69% more returns!
Citius Pharmaceuticals has performed better than Concord Medical in short term. Holding Citius Pharmaceuticals could be a better choice for now!
Baxter International has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Baxter International, about 8.6% more returns!
Dentsply Sirona has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Dentsply Sirona, about 6.23% more returns!
United Therapeutics has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in United Therapeutics, about 14.6% more returns!
Sellas Life has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Sellas Life, about 16.36% more returns!
Intellia Therapeutics has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Intellia Therapeutics, about 6.76% more returns!
Merus N has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Merus N, about 6.56% more returns!
Moleculin Biotech has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Moleculin Biotech, about 1383.15% more returns!
Masimo Corporation has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Masimo Corporation, about 4.57% more returns!
Livanova Plc has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Livanova Plc, about 31.19% more returns!
Kamada has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Kamada, about 11.91% more returns!
Irhythm Technologies has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Irhythm Technologies, about 7.76% more returns!
Amicus Therapeutics has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Amicus Therapeutics, about 17.21% more returns!
Cytosorbents Corporation has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Cytosorbents Corporation, about 8.42% more returns!
Citius Pharmaceuticals has performed better than Ac Immune in short term. Holding Citius Pharmaceuticals could be a better choice for now!
Citius Pharmaceuticals Technical analysis of indicators
Price action analysis of Citius Pharmaceuticals (CTXR) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Citius Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Citius Pharmaceuticals in short term but the buy signal is initial and weak.
Citius Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Citius Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Citius Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.27 and Citius Pharmaceuticals CTXR stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Citius Pharmaceuticals CTXR stock. Volume based technical analysis of Citius Pharmaceuticals CTXR stock is negative.
Citius Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock CTXR Citius Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And CTXR Experts View which covers a lot of information including buying and selling signals
CTXR future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Citius Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Citius Pharmaceuticals (CTXR) Technical (Analysis) Reports Citius Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
